Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report) insider Tracey Sacco sold 6,500 shares of the company's stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $33.08, for a total value of $215,020.00. Following the completion of the transaction, the insider now owns 71,750 shares in the company, valued at $2,373,490. This represents a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Scholar Rock Trading Down 1.6 %
Shares of Scholar Rock stock traded down $0.52 during trading on Friday, reaching $32.84. The company's stock had a trading volume of 1,129,184 shares, compared to its average volume of 1,171,222. The company has a market cap of $3.11 billion, a price-to-earnings ratio of -13.97 and a beta of 0.59. The firm's 50-day moving average is $37.74 and its two-hundred day moving average is $32.89. Scholar Rock Holding Co. has a 52-week low of $6.76 and a 52-week high of $46.98. The company has a quick ratio of 3.88, a current ratio of 3.88 and a debt-to-equity ratio of 0.63.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC lifted its stake in shares of Scholar Rock by 51.8% in the 4th quarter. GAMMA Investing LLC now owns 788 shares of the company's stock valued at $34,000 after acquiring an additional 269 shares during the last quarter. Quarry LP lifted its position in Scholar Rock by 3,443.3% in the third quarter. Quarry LP now owns 4,500 shares of the company's stock valued at $36,000 after purchasing an additional 4,373 shares during the last quarter. Global Retirement Partners LLC boosted its stake in shares of Scholar Rock by 584.7% during the fourth quarter. Global Retirement Partners LLC now owns 897 shares of the company's stock valued at $39,000 after purchasing an additional 766 shares during the period. Nisa Investment Advisors LLC boosted its stake in shares of Scholar Rock by 1,321.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,109 shares of the company's stock valued at $48,000 after purchasing an additional 1,031 shares during the period. Finally, GF Fund Management CO. LTD. bought a new position in shares of Scholar Rock in the fourth quarter worth approximately $85,000. 91.08% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Wedbush reissued an "outperform" rating and issued a $50.00 price target on shares of Scholar Rock in a research note on Tuesday. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, Scholar Rock currently has a consensus rating of "Buy" and an average target price of $42.67.
View Our Latest Stock Report on SRRK
About Scholar Rock
(
Get Free Report)
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.
Read More

Before you consider Scholar Rock, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.
While Scholar Rock currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.